English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Clinical Trials
Novotech is Gold Sponsor at Biotech Showcase 2023
Dec 20, 2022 11:00 HKT
数据显示 50% 的新试验位于亚太地区
Dec 16, 2022 07:00 HKT
數據顯示 50% 的新試驗位於亞太地區
Dec 16, 2022 07:00 HKT
자료 보고, 새로운 임상 시험 중 50%의 시험 장소가 아시아 태평양 지역에 위치
Dec 16, 2022 07:00 HKT
Data Shows 50% of New Trials Have Sites in Asia Pacific
Dec 15, 2022 10:00 HKT
Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding
Dec 14, 2022 21:45 HKT
Novotech 荣获 2022 年亚太地区 CRO 临床试验最佳实践奖
Dec 07, 2022 06:00 HKT
Novotech 榮獲 2022 年亞太地區 CRO 臨床試驗最佳實踐獎
Dec 07, 2022 06:00 HKT
노보텍, 임상 시험 모범 사례로 2022년 아시아 태평양 CRO 상 수상
Dec 07, 2022 06:00 HKT
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials
Dec 06, 2022 11:00 HKT
AJG Publishes Data from HighTide Therapeutics' Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis
Nov 17, 2022 08:00 HKT
Novotech, 동서 MRCT 전략 구축 및 자금 조달 방법에 대한 바이오 센추리 정상회담 워크숍 의장
Nov 12, 2022 14:00 HKT
Novotech 主持关于如何建立和资助东西方 MRCT 战略的 BioCentury 峰会研讨会
Nov 12, 2022 08:00 HKT
Novotech 主持關於如何建立和資助東西方 MRCT 戰略的 BioCentury 峰會研討會
Nov 12, 2022 08:00 HKT
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy
Nov 11, 2022 17:00 HKT
Avance Clinical赞助全球Scrip奖项的中国生物制药奖
Oct 27, 2022 08:00 HKT
Avance Clinical贊助全球Scrip獎項的中國生物製藥獎
Oct 27, 2022 08:00 HKT
중국에서의 임상 연구 기회와 미국 식품의약국 승인 경로 – 백서
Oct 27, 2022 07:00 HKT
中国的临床研究机会和美国食品药品监督管理局批准的途径 - 白皮书
Oct 26, 2022 07:00 HKT
中國的臨床研究機會和美國食品藥品監督管理局批准的途徑 - 白皮書
Oct 26, 2022 07:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: